United States. Code (U.S.C. o U.S.Code)
United States. United States" means the United States of America including the States thereof and the District of Columbia and its possessions (including Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, Wake Island and the Northern Mariana Islands).
United States. This document is not for distribution, directly or indirectly in or into the United States (as defined in Regulation S under the US Securities Act of 1933, as amended (the "Securities Act")).This document is not an offer of securities for sale in the United States, nor shall there be any offer of securities in any jurisdiction in which such offer or sale would be unlawful. The securities described in this press release may not be sold in the United States unless they are registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or are exempt from registration. The securities described in this press release have not been and will not be registered under the Securities Act and, accordingly, any offer or sale of Bonds may be made only in a transaction exempt from the registration requirements of the Securities Act. There will be no public offer of the securities in the United States or in any other jurisdiction
Examples of United States in a sentence
VV., Revitalizing antitrust in its II century, New York, 1991, p.6 Xxxxxxx, Xxxxx, Efficiencies issues in competition analysis in Australia, the European Union, and the United States, in Antitrust L.J., vol.64 1996 , p.
In the United States efficiencies are directly included within the analysis of the competitive effects of a merger and the agencies are increasingly taking these into account.
Products may be delivered worldwide, with the exclusion of the following countries: Antarctica, Australia, Brazil, China, Hong Kong, North Korea, South Korea, Netherlands, New Zealand, South Africa, Spain (Islands included), Sweden, Turkey, United States of America.
More Definitions of United States
United States. (US/ Rochester- NY) - Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19 Unique Protocol Identification Number: 20-003312 National Clinical Trial (NCT) Identified Number: 04338360 Version 3.0/ 09 April 2020 PROT/ PLA 01 Ed 1 rev. 0 del 26/04/2020 Pag. 14 a 23 ALLEGATI PROT/ PLA 01 Ed 1 rev. 0 del 26/04/2020 Pag. 15 a 23 CARTELLA CLINICA DEL PAZIENTE CANDIDATO A TRATTAMENTO CON PLASMA IPERIMMUNE ANTI SARS-CoV-2 DA DONATORE GUARITO Codice Paziente _ Centro di riferimento DATA di AVVIO DEL PROTOCOLLO: _ _/_ _/_ _ _ _ PROT/ PLA 01 Ed 1 rev. 0 del 26/04/2020 Pag. 16 a 23 CONDIZIONE CLINICA INIZIALE □ Paziente con CPAP (Terapia Subintensiva) □ Paziente intubato (Terapia intensiva) CRITERI DI INCLUSIONE □ Età maggiore o uguale a 18 anni; □ Pazienti con ARDS di tipo moderato o grave da ≤ 10 giorni con diagnosi di infezione da SARS-CoV-2, effettuata mediante ricerca biomolecolare (RT-PCR) su tampone nasale o su campione respiratorio profondo, che esibiscono: □ Nuovi sintomi respiratori o loro peggioramento entro una settimana dal loro esordio □ Immagini radiologiche di opacità polmonari bilaterali, atelectasia lobare o polmonare o presenza di noduli □ Insufficienza respiratoria non secondaria a insufficienza cardiaca o sovraccarico idrico □ PaO2/FiO2 ≤ 200 mm Hg (Tensione arteriosa di O2/Frazione ispirata di O2) con PEEP (o CPAP) ≥5 cmH2O; (PEEP: pressione positiva di fine espirazione) □ Incremento del valore di PCR di circa 3.5 volte (> 18 mg/dl) rispetto al basale □ Necessità di ventilazione meccanica e/o CPAP □ Sottoscrizione del consenso informato del paziente CRITERI DI ESCLUSIONE □ Diagnosi di ARDS moderata grave da oltre 10 giorni □ Pazienti con comprovata ipersensibilità o reazione allergica ad emoderivati ed Ig. □ Pazienti con deficit di Ig A; □ Accertato rifiuto ad aderire al protocollo di trattamento con plasma iperimmune Anamnesi personale DATI ANAGRAFICI ANAMNESI PATOLOGICA PROSSIMA ANAMNESI PATOLOGIA REMOTA □ Età anni □ M □ F □ Febbre □ Tosse □ Produzione di espettorato □ Rinorrea □ Faringodinia □ Nausea □ Vomito □ Nessuna □ Ipertensione arteriosa □ Dislipidemia □ Diabete mellito □ Tumori □ Altezza cm □ Peso Kg Fumo di sigarette: □ SI □ NO □ Diarrea □ Mialgia □ Artralgia □ Cefalea □ Congestione congiuntivale □ Dispnea per sforzo lieve □ Dispnea a riposo □ Difetto propriocettivo (anosmia, ageusia…) □ Malattia cardiovascolare (sindrome coronarica, vasculopatia periferica, arresto cardiaco, stroke….) □ Pneumopatia cronica ...
United States. (of America) VLOP Very large online platform VLOSE Very large online search engine VSP Video-sharing platform
United States. Code», paragrafo 659A,
United States. College of the Holy Cross United States Colorado State University United States Consortium - OhioLINK United States Xxxxxxx University Library, Ithaca, NY United States Xxxxxxxxx University United States DOE Argonne National Laboratory United States DOE Xxxxxxxxxx National Laboratory United States DOE Fermi National Accelerator Laboratory United States DOE Los Alamos National Laboratory United States DOE Oak Ridge National Laboratory United States DOE Pacific Northwest National Laboratory United States DOE SLAC National Accelerator Laboratory United States DOE Xxxxxx Xxxxxxxxx National Accelerator Facility United States Dartmouth College United States Duke University United States East Carolina University United States Emory University
United States. Energy Research and Development Administration, Stati Uniti d’America.
United States. Florida Atlantic University United States Florida Institute of technology
United States. Florida International University